Topics
Glioblastoma | Treatment | Antiepileptic drugs | Perampanel
Home > Publications > Topics > Glioblastoma > Treatment > Antiepileptic drugs > Perampanel
Heuer S, Burghaus I, Gose M,
Kessler T, Sahm F, Vollmuth P, Venkataramani V, Hoffmann D,
Schlesner M, Ratliff M, Hopf C, Herrlinger U, Ricklefs F, Bendszus
M, Krieg SM, Wick A, Wick W, Winkler F.
PerSurge
(NOA-30) phase II trial of perampanel
treatment
around surgery in patients with progressive glioblastoma.
BMC
Cancer. 2024 Jan
26;24(1):135. doi:
10.1186/s12885-024-11846-1. PMID:
38279087. Interventional
study protocol. ˍ
Eschen JT, Jensen LL, Hausmann D, Lind ANR, Lukacova S,
Weischenfeldt J, Lassen U, Westphal M, Winkler F, Simonsen U,
Korshoej AR.
SENIPERA Phase 0/1
randomized window-of-opportunity clinical trial of SENIcapoc and
PERAmpanel mono- and combination therapy of newly diagnosed
glioblastoma: a trial protocol.
BMC
Cancer. 2026 Apr 14;26(1):667. doi:
10.1186/s12885-026-15784-y. PMID:
41981510. Trial
registration ID: EU-CT: 2025–522605-37–00.
ˍ